These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21717227)

  • 21. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 22. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
    Wiesel FA; Farde L; Halldin C
    Acta Psychiatr Scand Suppl; 1989; 352():30-4. PubMed ID: 2573239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawal of antiparkinson drugs.
    Orlov P; Kasparian G; DiMascio A; Cole JO
    Arch Gen Psychiatry; 1971 Nov; 25(5):410-2. PubMed ID: 5133814
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of efficacy of timiperone, a new butyrophenone derivative, and clocapramine in schizophrenia: a multiclinic double-blind study.
    Nakazawa T; Ohara K; Sawa Y; Edakubo T; Matsui H; Sawa J; Kawaguchi K; Hattori S; Nakajima M
    J Int Med Res; 1983; 11(5):247-58. PubMed ID: 6139317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind study with two butyrophenone derivatives: bromperidol vs. haloperidol.
    Pöldinger W; Bures E; Haage H
    Int Pharmacopsychiatry; 1977; 12(3):184-92. PubMed ID: 334688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methylperon. (Buronil "Ferrosan"). A new butyrophenone neuroleptic].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1972 Jan; 92(3):192-3. PubMed ID: 5016100
    [No Abstract]   [Full Text] [Related]  

  • 28. [C.B. 8089 (FLUORIZED BUTYROPHENONE) IN STATES OF PSYCHOMOTOR AGITATION AND IN CHARACTER DISORDERS AT ALL AGES (EXCEPT CHILDHOOD)].
    CHATAGNON PA; CHATAGNON C
    Ann Med Psychol (Paris); 1964 May; 122():809-16. PubMed ID: 14150706
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the use of sulpiride in psychiatric therapy].
    Naviau J
    Ann Med Psychol (Paris); 1969 Jun; 2(1):108-16. PubMed ID: 5376631
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypothermia during use of pipamperone].
    Eikenboom HC; Janssens AR; Rosekrans PC; Molendijk W
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):301-3. PubMed ID: 9148168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and therapy of the secondary disease: psychiatry].
    Burchard JM
    Int J Clin Pharmacol; 1973 Dec; 8(4):333-6. PubMed ID: 4150765
    [No Abstract]   [Full Text] [Related]  

  • 32. Risks vs. benefits of antipsychotic drugs.
    Baldessarini RJ; Lipinski JF
    N Engl J Med; 1973 Aug; 289(8):427-8. PubMed ID: 4146359
    [No Abstract]   [Full Text] [Related]  

  • 33. Practical clinical psychopharmacology: the tranquilizers.
    Snodgrass RE
    J Indiana State Med Assoc; 1975 Oct; 68(10):883-7. PubMed ID: 1194695
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correction by dihydroergotamine of arterial pressure disorders induced by psychiatric chemotherapy].
    Kammerer T; Tyano S
    Ann Med Psychol (Paris); 1968 Feb; 1(2):269-75. PubMed ID: 5651950
    [No Abstract]   [Full Text] [Related]  

  • 35. [Side effects of methylperone in long-term therapy up to 8 years].
    Kirkegaard G; Kirkegaard A
    Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Differentiation between neuroleptic antipsychotic properties and side effects by subgroups of dopaminergic neurons.
    Bunney BS; Aghajanian GK
    Psychopharmacol Bull; 1974 Oct; 10(4):17-8. PubMed ID: 4473793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Follow-up treatment of endogenous psychoses].
    Lieser H
    Munch Med Wochenschr; 1967 Aug; 109(32):1663-7. PubMed ID: 4385551
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of 4-hydroxybutyric acid in psychotic agitation. Preliminary report].
    Pèrez-Rincón H
    Neurol Neurocir Psiquiatr; 1969; 10(3):169-74. PubMed ID: 5406974
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-acting neuroleptics. 5 years of observations].
    Dencker SJ
    Lakartidningen; 1972 Mar; 69():85-8. PubMed ID: 4664129
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
    Tetreault L; Filotto J; Bordeleau JM
    Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.